Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 361 - 370 of 711 results

First page
Previous page
Next page
Next page

POLYURETHANE-35 (NOT MORE THAN 1000 MPA.S AT 40%)

M50EV976QC

Status:

Possibly Marketed Outside US

Source:

M016

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25217ab7-a44f-0df9-e063-6394a90a8700

First approved in 2024

Source:

M016

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25217ab7-a44f-0df9-e063-6394a90a8700

Class:

POLYMER

POLYGLYCERYL-10 ISOSTEARATE

ZLW9022RH1

Status:

Possibly Marketed Outside US

Source:

M020

(2025)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=300ab1bc-9c11-c2f0-e063-6394a90aa853

First approved in 2024

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=20a83f02-d851-4aac-e063-6394a90ae1a6

Class:

POLYMER

PEG-5 CAPRYLIC/CAPRIC GLYCERIDES

S0SPK283TZ

Status:

Possibly Marketed Outside US

Source:

M020

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15c61d10-52fd-8793-e063-6394a90a7d8f

First approved in 2024

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15c61d10-52fd-8793-e063-6394a90a7d8f

Class:

POLYMER

PEG/PPG-4/30 COPOLYMER

6SG11EPD3Z

Status:

Possibly Marketed Outside US

Source:

M006

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=226ad777-6e2d-b72d-e063-6394a90aa363

First approved in 2024

Source:

M006

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=226ad777-6e2d-b72d-e063-6394a90aa363

Class:

POLYMER

BIS(CYSTEINYL MALEIMIDE) PEG 20000

218XKZ42TQ

Status:

Possibly Marketed Outside US

Source:

M016

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1efb3b21-d0e8-adb1-e063-6394a90aadde

First approved in 2024

Source:

M016

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1efb3b21-d0e8-adb1-e063-6394a90aadde

Class:

POLYMER

MPEG-400-GLY-NEU-GALNAC-THR

9U1BHC877U

Status:

Possibly Marketed Outside US

Source:

M017

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22f5147e-ff2b-4ae8-e063-6394a90a4e54

First approved in 2024

Source:

M019

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f157030-1bf5-6bf7-e063-6294a90add4c

Class:

POLYMER

N-CARBOXYMETHYLCHITOSAN

5R88W82CC6

Status:

Possibly Marketed Outside US

Source:

M012

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f12618b-7461-fb47-e063-6294a90af753

First approved in 2024

Source:

M012

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f12618b-7461-fb47-e063-6294a90af753

Class:

POLYMER

PEG-60 STEARATE

7TB32G765E

Status:

Possibly Marketed Outside US

Source:

M020

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10a95d0a-366f-0611-e063-6294a90abb44

First approved in 2024

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10a95d0a-366f-0611-e063-6294a90abb44

Class:

POLYMER

LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 140000 MW)

599BTP6K9F

Status:

Possibly Marketed Outside US

Source:

Vivant True Tone Forte by Vivant Pharmaceuticals, LLC

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10b923cc-1486-cd97-e063-6294a90a95d1

First approved in 2024

Source:

Vivant True Tone Forte by Vivant Pharmaceuticals, LLC

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10b923cc-1486-cd97-e063-6294a90a95d1

Class:

POLYMER

SODIUM OLETH SULFATE

3MX3FTR4XP

Status:

Possibly Marketed Outside US

Source:

M032

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29a84b05-f299-92de-e063-6294a90af8c5

First approved in 2024

Source:

M032

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29a84b05-f299-92de-e063-6294a90af8c5

Class:

POLYMER

Structure of POLYURETHANE-35 (NOT MORE THAN 1000 MPA.S AT 40%)

Polymer

POLYURETHANE-35 (NOT MORE THAN 1000 MPA.S AT 40%)

Structure of POLYGLYCERYL-10 ISOSTEARATE

Polymer

POLYGLYCERYL-10 ISOSTEARATE

Structure of PEG-5 CAPRYLIC/CAPRIC GLYCERIDES

Polymer

PEG-5 CAPRYLIC/CAPRIC GLYCERIDES

Structure of PEG/PPG-4/30 COPOLYMER

Polymer

PEG/PPG-4/30 COPOLYMER

Structure of BIS(CYSTEINYL MALEIMIDE) PEG 20000

Polymer

BIS(CYSTEINYL MALEIMIDE) PEG 20000

Structure of MPEG-400-GLY-NEU-GALNAC-THR

Polymer

MPEG-400-GLY-NEU-GALNAC-THR

Structure of N-CARBOXYMETHYLCHITOSAN

Polymer

N-CARBOXYMETHYLCHITOSAN

Structure of PEG-60 STEARATE

Polymer

PEG-60 STEARATE

Structure of LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 140000 MW)

Polymer

LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 140000 MW)

Structure of SODIUM OLETH SULFATE

Polymer

SODIUM OLETH SULFATE

Showing 361 - 370 of 711 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1